American depositary receipt

INVESTOR ALERT: LKLSG Notifies Shareholders of Evolution AB (publ) (EVVTY) About Pending Securities Class Action Lawsuit and Important March 25, 2024, Deadline

Retrieved on: 
Monday, March 18, 2024

Its American Depositary Shares ("ADSs") trade in the OTC Market in the United States under the ticker EVVTY.

Key Points: 
  • Its American Depositary Shares ("ADSs") trade in the OTC Market in the United States under the ticker EVVTY.
  • The lawsuit alleges that when the true facts were revealed to the market, the EVVTY share price dropped, damaging its investors.
  • If you are a member of the class, you can be represented by counsel without paying any out-of-pocket attorney's fees or costs.
  • LKLSG's lawyers have secured hundreds of millions of dollars for investors and consumers in class action and other complex litigation cases, including securities class actions.

TCBP Announces Exercise of Series D Warrants For Cash

Retrieved on: 
Monday, March 18, 2024

EDINBURGH, Scotland, March 18, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that an institutional investor has exercised cash only warrants represented 623,750 American Depository Shares (ADS) at an exercise price of $2.02.

Key Points: 
  • The gross proceeds of the warrant exercise was $1,263,000 with a net cash infusion of $1,168,275 to the Company post fees associated with the exercise to HC Wainwright & Co.
  • There was no additional consideration or inducement paid for the exercise of the Series D warrants in this transaction.
  • "This transaction is further reflective of the promise of TCB-008 and The Company as whole," stated CEO Bryan Kobel.
  • "We will continue to execute on our 2024 plan, driving to human data in AML as well as expanding our platform.

EVVTY DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Evolution AB (publ) Investors with Losses in Excess of $100K to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EVVTY

Retrieved on: 
Sunday, March 17, 2024

WHAT TO DO NEXT: To join the Evolution class action, go to https://rosenlegal.com/submit-form/?case_id=22119 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Evolution class action, go to https://rosenlegal.com/submit-form/?case_id=22119 or call Phillip Kim, Esq.
  • If you wish to serve as lead plaintiff, you must move the Court no later than March 25, 2024.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

NaaS Technology Inc. Announces Closing of US$6 Million Registered Direct Offering

Retrieved on: 
Friday, March 15, 2024

BEIJING, March 15, 2024 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S. listed EV charging service company in China, today announced the closing of its registered direct offering of 4,761,905 American Depositary Shares ("ADS") together with warrants to purchase up to 4,761,905 ADSs at a combined purchase price of US$1.26 per ADS and accompanying warrant (together the "Securities") for total gross proceeds of approximately US$6 million, before deducting commissions and other estimated offering expenses.

Key Points: 
  • BEIJING, March 15, 2024 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S. listed EV charging service company in China, today announced the closing of its registered direct offering of 4,761,905 American Depositary Shares ("ADS") together with warrants to purchase up to 4,761,905 ADSs at a combined purchase price of US$1.26 per ADS and accompanying warrant (together the "Securities") for total gross proceeds of approximately US$6 million, before deducting commissions and other estimated offering expenses.
  • The warrants have an exercise price of US$1.49, will be exercisable beginning six months following the date of issuance and will expire five years from the initial exercise date.
  • This offering is being made pursuant to an effective shelf registration statement on Form F-3 (File No 333-273515) previously filed with the U.S. Securities and Exchange Commission (the "SEC").
  • A prospectus supplement describing the terms of the proposed offering has been filed with the SEC on March 14, 2024.

SOS Ltd. Announces Pricing of $7.85 Million Public Offering

Retrieved on: 
Wednesday, March 13, 2024

The gross proceeds to the Company from the follow-on offering are estimated to be $7.85 million before deducting the placement agent's fees and other estimated offering expenses.

Key Points: 
  • The gross proceeds to the Company from the follow-on offering are estimated to be $7.85 million before deducting the placement agent's fees and other estimated offering expenses.
  • The public offering is expected to close on or about March 15, 2024, subject to the satisfaction of customary closing conditions.
  • The offering is being made only by means of a prospectus which is a part of the Registration Statement.
  • A preliminary prospectus relating to the offering has been filed with the SEC and available on the SEC's website at http://www.sec.gov .

NaaS Technology Inc. Announces US$6 Million Registered Direct Offering

Retrieved on: 
Wednesday, March 13, 2024

The warrants will have an exercise price of US$1.49, will be exercisable beginning six months following the date of issuance and will expire five years from the initial exercise date.

Key Points: 
  • The warrants will have an exercise price of US$1.49, will be exercisable beginning six months following the date of issuance and will expire five years from the initial exercise date.
  • The closing of the offering and sale of the Securities is expected to occur on or about March 15, 2024, subject to the satisfaction of customary closing conditions.
  • This offering is being made pursuant to an effective shelf registration statement on Form F-3 (File No 333-273515) previously filed with the U.S. Securities and Exchange Commission (the "SEC").
  • A prospectus supplement describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC's website located at http://www.sec.gov .

Receipts Depositary Corporation (RDC) Appoints Scott Pollak Head of Strategy and Capital Markets

Retrieved on: 
Tuesday, March 12, 2024

NEW YORK, March 12, 2024 /PRNewswire/ -- Receipts Depositary Corporation (RDC) today announced the appointment of Scott Pollak as Head of Strategy and Capital Markets. Pollak joins following RDC's launch earlier this year and is the former managing director and global head of depositary receipts at Citi. 

Key Points: 
  • NEW YORK, March 12, 2024 /PRNewswire/ -- Receipts Depositary Corporation (RDC) today announced the appointment of Scott Pollak as Head of Strategy and Capital Markets.
  • Pollak joins following RDC's launch earlier this year and is the former managing director and global head of depositary receipts at Citi.
  • He spent over 14 years in a variety of leadership positions at Citi's depositary receipts business, most recently as its global leader.
  • "Depositary receipts provide institutional buyers with a tried and tested solution that makes it as easy to own digital and alternative assets as any traditional security," said Scott Pollak.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of JBS S.A. - JBSAY

Retrieved on: 
Monday, March 11, 2024

NEW YORK, March 11, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of JBS S.A. ("JBS" or the "Company") (OTC: JBSAY).

Key Points: 
  • NEW YORK, March 11, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of JBS S.A. ("JBS" or the "Company") (OTC: JBSAY).
  • The investigation concerns whether JBS and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • On February 28, 2024, Reuters published an article entitled "New York sues meatpacking giant JBS over climate claims."
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Evolution AB (publ) Investors to Secure Counsel Before Important Deadline in Securities Class Action - EVVTY

Retrieved on: 
Wednesday, March 6, 2024

WHAT TO DO NEXT: To join the Evolution class action, go to https://rosenlegal.com/submit-form/?case_id=22119 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Evolution class action, go to https://rosenlegal.com/submit-form/?case_id=22119 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Renesas Extends Tender Offer for Proposed Acquisition of Sequans

Retrieved on: 
Tuesday, February 20, 2024

Shareholders to Receive U.S. $0.7575 per Ordinary Share and U.S. $3.03 per ADS in cash

Key Points: 
  • Renesas is of the opinion that this confirmation constitutes an Adverse Japanese Tax Ruling under the Memorandum of Understanding and, therefore, the contractual condition in the Memorandum of Understanding to the tender offer requiring Renesas' receipt of a confirmation that such reorganization not trigger such tax cannot be fulfilled.
  • On February 12, 2024, the parties closed another financing transaction in which a wholly owned subsidiary of Renesas loaned an additional $9,000,000 to Sequans in exchange for an unsecured subordinated note of Sequans.
  • The tender offer was extended to allow additional time for the satisfaction of the remaining closing conditions of the tender offer, including, but not limited to, the valid tender of ordinary shares and ADSs of Sequans representing - together with ordinary shares and ADSs of Sequans beneficially owned by Renesas, if any - at least 90% of the fully diluted ordinary shares of Sequans.
  • The Bank of New York Mellon, the Tender Agent for the tender offer, has advised Renesas that as of 6 p.m., New York City time, on February 16, 2024, approximately 123,472,744 ordinary shares of Sequans (including ordinary shares represented by ADSs), representing approximately 44.5% of the fully diluted ordinary shares of Sequans, have been validly tendered and not properly withdrawn pursuant to the tender offer.